Avoid common mistakes on your manuscript.
Case report
Dr. Martellucci
We present a case of Caucasian 36-year-old man, presenting the Emergency Department (ED) after performing blood test for asthenia, revealing a severe anemia (hemoglobin 6.1 g/dL), associated with iron deficiency, increased C-Reactive protein (CRP) levels, erythro-sedimentation rate, altered liver enzymes (AST and ALT), increased number of platelets (more than one million/mm3). Hypocholesterolemia, hypotriglyceridemia, and high direct hyperbilirubinemia were also present.
The patient referred only tiredness and the absence of evident bleeding. The work activity was personal trainer and in clinical history: diagnosis of Marcus Gunn syndrome and abuse of anabolic androgenic steroids for body building for 9 years. The patient denied smoking and alcohol intake, as well as exposure to environmental toxicants. The family history was negative for cardio-pulmonary diseases, as well as cancer and diabetes. In ED the vital parameters were within normal range. Cardiac and thoracic physical examination were without alterations. The abdomen was difficult to evaluate due to hypertrophy of the rectus abdominis muscles. The blood tests confirmed the severe anemia, and showed high levels of CRP (21 times above the normal values), AST, ALT, gamma-glutamyl transferase (GGT), lactate dehydrogenase (LDH), abnormal platelets values and high direct bilirubinemia (1.74 mg/dL). Pseudocholinesterase was reduced and the SARS Cov-2 swab (RT-PCR) resulted negative. A blood transfusion and abdominal CT were performed. The CT scan performed at the ED showed a voluminous (15 cm) neoformation localized in the middle and upper third of the right kidney with inhomogeneous appearance due to the presence of colliquative areas, calcifications and no clear signs of active bleeding in the lesion. In addition, the radiologist described a significantly enlarged steatotic liver with an hypervascular nodular neoformation (15 mm) (IV hepatic segment) presenting with rapid washout. The patient was transfused with additional two units of blood and again after 4 days. The saturation of transferrin was 8.4% and reticulocytes, after transfusion, were 131.000 cells/mm3, with aptoglobine levels within normal range.
Dr. Melena
Upon admission to our Internal Medicine Unit, the patient was in stable clinical condition, with fever (37.8 °C) and heart rate of 110 bpm. Hepatomegaly was detected at physical examination. For the presence of fever, blood cultures were requested, resulting negative. Additional blood tests were normal with exception of increased tumor antigen CA 15.3, transaminases, the presence of iron deficiency and thrombocytosis.
Considering the steroids abuse, an echocardiography, a total body CT scan and an abdominal MRI were performed. The patient was the transfused several times in our Unit (due to hemoglobin levels below 8 g/dL). The echocardiography, performed due to the high prevalence of cardiovascular risk and testosterone [1], showed: left ventricle of dimensions at the upper limits with increased wall thickness. Preserved ejection fraction. A dilatation of the left atrium. Mild to moderate mitral insufficiency. Mild tricuspid insufficiency. The CT scan (Fig. 1) confirmed the right renal neoformation and an enlarged left kidney with preserved cortico-medullary structure and hepatomegaly with a longitudinal diameter of 37 cm. In the liver three nodular formations (max 15 mm) in the III, IV and VI segments with enhancement in the arterial phase and washout in the venous and late phases (excluding thrombosis, which is often associated with cancer [2, 3]) were described compatible with transient hepatic attenuation differences (THAD), a hepatic perfusion anomaly [4] as also confirmed by MRI (Fig. 2).
Dr. Assanto and Prof. Molfino
After an interdisciplinary meeting, including internists, radiologist, abdominal surgeon, urologist and oncologist, nephrectomy was indicated as the primary treatment for the patient. Gastroscopy and colonoscopy, before surgery, excluded gastrointestinal bleeding. At Urology Unit total right nephrectomy and hepatic lesions biopsy, during surgery, were performed, without complications. Histological examination confirmed a clear-cell renal carcinoma (ccRC) with no vascular or capsular invasion and the liver biopsy revealed a hepatocellular adenoma. The patient was then discharged in good condition with subsequent outpatient follow-up.
Discussion
Prof. Molfino, Dr. Giovannetti, and Prof. Muscaritoli
Renal cell carcinoma accounts for approximately 2.4% of all malignancies among the adult’s population [5].
The ccRC accounts for approximately 60% of malignant renal neoplasms. Several environmental factors have been identified as contributing causes of the disease, including cigarette smoking, obesity, and hypertension [6, 7], and age like in other type cancers [8].
National and international guidelines do not include steroids abuse as risk factor for renal cancer [9, 10], but some cases of prolonged abuse of steroids associated with ccRC are available in the literature.
Dr. Martellucci
Body builders often assume very high doses of anabolic steroids—even much higher than patient on hormonal replacement therapy for hypogonadism—determining testicular function’s suppression with a decrease in testosterone serum concentration and an increase in estrogens with potential tumor-inducing effects [11]. The association between cancer and use of anabolic androgenic steroids has been described in hepatocellular and prostatic cancers and also with Wilm’s tumor [11] but there is no evidence of a direct association with renal cancer. It has been suggested that patients with a preexisting condition, such as an adenoma, the action of steroids could determine malignant transformation [11, 12]. In particular, authors described only few cases of clear-cell renal cancer in body builders exposed to chronic steroids’ abuse (ranging from 20 months to 15 years of steroids abuse) presenting often with hematuria and anemia as initial symptoms [11, 13, 14].
All the authors
Renal cell carcinomas occur more frequently in adults older than 60 years. Besides the well-known risk factors (previously indicated), some genetic alterations in younger adults and in pediatric population have been reported [7]. The majority of RCC in the general population is sporadic, whereas those occurring in children and young individuals are often determined by specific germline gene mutations [7]. Analgesics have been also associated with higher risk to develop RCC, including aspirin and acetominophen [7]. Therefore, nowadays strategies aimed at reducing RRC risk should be focused on the improvement of both environment and behavioral factors and at managing the associated comorbidities to avoid complications.
The description of our clinical case adds an important information on a possible dangerous and life-threatening association between steroids abuse and renal cancer. We strongly advice to study and clarify the link between abuse of anabolic androgenic steroids and cancer transformation, specifically renal carcinomas in younger adults.
References
Tirabassi G, Gioia A, Giovannini L, Boscaro M, Corona G, Carpi A et al (2013) Testosterone and cardiovascular risk. Intern Emerg Med 8(Suppl 1):S65–S69
Prisco D, Tufano A, Cenci C, Pignatelli P, Santilli F, Di Minno G et al (2019) Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer. Intern Emerg Med 14(1):21–38
Spiezia L, Simioni P (2010) Upper extremity deep vein thrombosis. Intern Emerg Med 5(2):103–109
Parrinello G, Torres D, Licata G (2011) Giant area of transient hepatic attenuation difference, mimicking incidentaloma at liver ultrasound. Intern Emerg Med 6(2):177–179
World Health Organization (WHO). Global Health Estimates 2020 (2020) Deaths by cause, age, sex, by country and by region, 2000–2019. WHO, Geneva
Macleod LC, Hotaling JM, Wright JL, Davenport MT, Gore JL, Harper J, White E (2013) Risk factors for renal cell carcinoma in the VITAL study. J Urol 190(5):1657–1661
Makino T, Kadomoto S, Izumi K, Mizokami A (2022) Epidemiology and prevention of renal cell carcinoma. Cancers 14(16):4059
Monfardini S, Falci C, Brunello A, Lonardi S, Basso U (2011) Cancer in the elderly. Intern Emerg Med 6(Suppl 1):115–118
Linee guida tumori del rene (2020/2021). https://www.aiom.it/linee-guida-aiom-2021-tumori-del-rene/
Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V et al (2019) Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(5):706–720
Martorana G, Concetti S, Manferrari F, Creti S (1999) Anabolic steroid abuse and renal cell carcinoma. J Urol 162(6):2089
Zhao J, Eyzaguirre E (2019) Clear cell papillary renal cell carcinoma. Arch Pathol Lab Med 143(9):1154–1158
Pärssinen M, Seppälä T (2002) Steroid use and long-term health risks in former athletes. Sports Med 32(2):83–94
Rosner F, Khan MT (1992) Renal cell carcinoma following prolonged testosterone therapy. Arch Intern Med 152(2):426–429
Funding
This article was produced without any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.The patient provided informed consent for the use of his clinical data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Molfino, A., Martellucci, O., Melena, M. et al. A 36-year-old man, body builder presenting with unexpected severe anemia. Intern Emerg Med 18, 1477–1479 (2023). https://doi.org/10.1007/s11739-023-03253-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-023-03253-4